Literature DB >> 12133595

MT1 melatonin receptor mRNA expression exhibits a circadian variation in the rat suprachiasmatic nuclei.

Vincent-Joseph Poirel1, Mireille Masson-Pévet, Paul Pevét, François Gauer.   

Abstract

The aim of the present study was to investigate the daily regulation of both MT1 and MT2 melatonin receptor subtype mRNA expression in the rat SCN in order to clarify their role in the daily variation of SCN melatonin receptors. Existing MT1 and MT2 partial clones were extended by PCR to 982 and 522 bp, respectively. However, while the MT1 clone allowed us to set up a highly sensitive in situ hybridization (ISH) method, we could not detect MT2 expression within the SCN. Therefore, our results suggest that only MT1 mRNA can be correlated with 2-iodo-melatonin binding sites in the rat SCN. Investigation of MT1 mRNA expression throughout the 24 h light/dark cycle or in constant darkness clearly showed that in the two conditions, mRNA expression showed a robust rhythm with two peaks, one after the day/night and one after the night/day transitions in LD, and at the beginning of the subjective night and day in DD, respectively. Furthermore, these variations were not linked to the daily changes in melatonin receptor density. Thus, the transcriptional regulation of MT1 receptors does not appear to play a role in the daily regulation of melatonin binding sites availability.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12133595     DOI: 10.1016/s0006-8993(02)02824-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  The orphan GPR50 receptor specifically inhibits MT1 melatonin receptor function through heterodimerization.

Authors:  Angélique Levoye; Julie Dam; Mohammed A Ayoub; Jean-Luc Guillaume; Cyril Couturier; Philippe Delagrange; Ralf Jockers
Journal:  EMBO J       Date:  2006-06-15       Impact factor: 11.598

2.  Late evening brain activation patterns and their relation to the internal biological time, melatonin, and homeostatic sleep debt.

Authors:  Tali Gorfine; Nava Zisapel
Journal:  Hum Brain Mapp       Date:  2009-02       Impact factor: 5.038

Review 3.  Functional MT1 and MT2 melatonin receptors in mammals.

Authors:  Margarita L Dubocovich; Magdalena Markowska
Journal:  Endocrine       Date:  2005-07       Impact factor: 3.633

4.  The presence and localization of melatonin receptors in the rat aorta.

Authors:  Martin Schepelmann; Lubos Molcan; Hana Uhrova; Michal Zeman; Isabella Ellinger
Journal:  Cell Mol Neurobiol       Date:  2011-06-22       Impact factor: 5.046

5.  International Union of Basic and Clinical Pharmacology. LXXV. Nomenclature, classification, and pharmacology of G protein-coupled melatonin receptors.

Authors:  Margarita L Dubocovich; Philippe Delagrange; Diana N Krause; David Sugden; Daniel P Cardinali; James Olcese
Journal:  Pharmacol Rev       Date:  2010-07-06       Impact factor: 25.468

6.  Melatonin in the mammalian olfactory bulb.

Authors:  J T Corthell; J Olcese; P Q Trombley
Journal:  Neuroscience       Date:  2013-12-21       Impact factor: 3.590

Review 7.  Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new?

Authors:  R Jockers; P Maurice; J A Boutin; P Delagrange
Journal:  Br J Pharmacol       Date:  2008-05-19       Impact factor: 8.739

8.  Gene structures, biochemical characterization and distribution of rat melatonin receptors.

Authors:  Hirotaka Ishii; Nobuyuki Tanaka; Momoko Kobayashi; Masakatsu Kato; Yasuo Sakuma
Journal:  J Physiol Sci       Date:  2008-12-06       Impact factor: 2.781

Review 9.  Neurobiology of circadian rhythm sleep disorders.

Authors:  Prasanth Manthena; Phyllis C Zee
Journal:  Curr Neurol Neurosci Rep       Date:  2006-03       Impact factor: 5.081

10.  Melatonin receptors limit dopamine reuptake by regulating dopamine transporter cell-surface exposure.

Authors:  Abla Benleulmi-Chaachoua; Alan Hegron; Marine Le Boulch; Angeliki Karamitri; Marta Wierzbicka; Victoria Wong; Igor Stagljar; Philippe Delagrange; Raise Ahmad; Ralf Jockers
Journal:  Cell Mol Life Sci       Date:  2018-07-24       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.